# US 2011/0301259 A1 · Temporal intraluminal stent, methods of making and using

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0301259 A1
- Document ID: US20110301259A1
- Status: Published application
- Kind: A1
- Application number: 13/206,430
- Filed: 2011-08-09
- Published: 2011-12-08
- Earliest claimed: 2006-10-25
- Assignees: Biosensors International Group, Ltd.
- Inventors: Shih-Horng Su; John E. Shulze; Debashis Dutta; John Nguyen
- Web page: https://patentgrep.com/patent/US20110301259A1

## CPC

- A61F 2/86: Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F 2/91: made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F 2/915: with bands having a meander structure, adjacent bands being connected to each other
- B29C 41/14: Dipping a core {(B29C41/10 takes precedence)}
- A61F 2/88: the wire-like elements formed as helical or spiral coils
- A61F 2002/828: {Means for connecting a plurality of stents allowing flexibility of the whole structure}
- A61F 2002/91525: {within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude}
- A61F 2002/91541: {Adjacent bands are arranged out of phase}
- A61F 2002/91558: {connected peak to peak}
- A61F 2002/91566: {connected trough to trough}
- A61F 2002/91591: {Locking connectors, e.g. using male-female connections}
- A61F 2210/0076: multilayered, e.g. laminated structures
- B29C 41/34: Component parts, details or accessories; Auxiliary operations
- B29K 2067/046: {PLA, i.e. polylactic acid or polylactide}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS

## Abstract

A biodegradable polymer stent with radiopacity and a method of making and using a stent with enhanced mechanical strength and/or controlled degradation for use in a bodily lumen is described.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A biodegradable polymer stent comprising an aliphatic polyester polymer and a salt selected from the group of salts: phosphate buffer salt, citrate buffer salt and sodium chloride wherein the salt is present in an amount sufficient to increase the degradation rate compared to the same stent without the salt.

### Claim 32 (depends on 31)

The stent of claim 31 wherein the salt comprises from 0.01 to 15% of the percent weight of the stent.

### Claim 33 (depends on 31)

The stent of claim 31 wherein the salt comprises from 2.0 to 8% of the percent weight of the stent.

### Claim 34 (depends on 31)

The stent of claim 31 wherein the salt is a phosphate salt.

### Claim 35 (depends on 31)

The stent of claim 31 wherein the polymer is comprised of poly-L-lactic acid or poly D,L-lactic acid.

### Claim 36 (depends on 31)

The stent of claim 31 wherein the polymer is a homo-polymer.

### Claim 37 (depends on 31)

The stent of claim 31 wherein the polymer is a co-polymer.

### Claim 38

A method of increasing the rate of biodegradation of a biodegradable polymer stent comprising an aliphatic polyester polymer and a salt selected from the group of salts: phosphate buffer salt, citrate buffer salt and sodium salt comprising the steps of:
i. combining the salt with the polymer in an amount sufficient to increase the degradation rate compared to the same stent without the salt; and,
ii. forming the polymer into a stent.

### Claim 39 (depends on 38)

The method of claim 38 wherein the salt comprises from 0.01 to 15% of the percent weight of the stent.

### Claim 40 (depends on 38)

The method of claim 38 wherein the salt comprises from 2.0 to 8% of the percent weight of the stent.

### Claim 41 (depends on 38)

The method of claim 38 wherein the salt is a phosphate salt.

### Claim 42 (depends on 38)

The method of claim 38 wherein the polymer is comprised of poly-L-lactic acid or poly D,L-lactic acid.

### Claim 43 (depends on 38)

The method of claim 38 wherein the polymer is a homo-polymer.

### Claim 44 (depends on 38)

The method of claim 38 wherein the polymer is a co-polymer.
